The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

Medical device maker Dexcom said on Tuesday it will invest $75 million in Ōura's latest funding round, valuing the smart ring maker at over $5 billion.

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for ...

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.

DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital signs and biometrics.

Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the company's products to ...

Diabetes care device developer Dexcom and ŌURA, maker of the Oura smart ring, have announced a strategic partnership that aim ...

Smart ring company Oura announced it received $75 million in funding from glucose monitoring and diagnostics company Dexcom.

Dexcom and ŌURA announce a strategic partnership to help millions of people improve their metabolic health through the integration of Dexcom glucose data with vital sign, sleep, stress, heart health ...

Dexcom has rounded up its celebrity spokespeople for World Diabetes Day, putting singer Nick Jonas at the center of a campaign intended to help people change their perception of what they can achieve.

In 2025 the Oura Ring will integrate with Dexcom glucose sensorsDexcom data will sit alongside other health points within the ...

In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other high growth large cap stocks. BlackRock highlighted that its portfolio managers are broadly ...